Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

FB to Challenge EBAY With Auction Feature

By Greg Gambone, InvestorPlace Contributor May 14, 2015

There have been reports of an EBAY-style sales platform coming to FB. If successful, the new feature could be devastating to eBay.

JCP Stock Is a Better Buy Than Its Earnings Response Suggests

By James Brumley, InvestorPlace Feature Writer May 14, 2015

For patient investors who can see more than a few months down the road, JCP stock actually offers more reward than risk.

5 Stocks With Superb Earnings Surprises — ABMD UBA WRI RDCM BRE

By Portfolio Grader May 14, 2015

This week, these five stocks have the best ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

Healthcare Stocks Showdown: UNH vs. ANTM

By Louis Navellier, Editor, Growth Investor May 14, 2015

When choosing your favorite healthcare stocks, you must decide -- are you a people person or a systems person? We'll compare UNH stock and ANTM stock.

4 Commercial Services Stocks to Buy Now

By Portfolio Grader May 13, 2015

The grades of four commercial services stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

5 Biotechnology Stocks to Buy Now

By Portfolio Grader May 13, 2015

The grades of five biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

SONC: Drive Away With Profits on This Small-Cap Stock

By John Jagerson and Wade Hansen May 13, 2015

There are three important factors working in the favor of Sonic Corporation. Although overlooked by many, SONC stock is set to drive higher.

6 Insurance Stocks to Buy Now

By Portfolio Grader May 13, 2015

This week, six insurance stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

Medivation Stock – Jump Ahead of the Future With MDVN

By Louis Navellier, Editor, Growth Investor May 13, 2015

Medivation (MDVN) is the latest iteration of the new breed of biotech stocks that are changing the medical landscape.

ARM Holdings: ARMH Gets Ready for Liftoff

By Charles Payne May 13, 2015

ARM Holdings has a great business model in licensing out its ideas. ARMH stock should be a strong growth stock and could reach $75 per share.

3 Blue Chips You Should Love for Their Short Squeeze Potential

By Johnson Research Group May 13, 2015

These three blue chips are actually reaping multiple benefits from short interest -- but naturally, what we love most are their chances for a short squeeze higher.

5 Semiconductor Stocks to Buy Now

By Portfolio Grader May 13, 2015

This week, five semiconductor stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

10 Best “Strong Buy” Stocks — JBLU IPXL ELLI and more

By Portfolio Grader May 13, 2015

This week, these ten stocks, all currently earning A's ("strong buy") on Portfolio Grader, have the best year-to-date performance.

5 Stocks With Great Earnings Momentum — KNSY FTEK QLYS EVAC CEB

By Portfolio Grader May 13, 2015

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

21 Upgraded Blue-Chip Stocks to Buy

By Louis Navellier, Editor, Growth Investor May 13, 2015

After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise rankings for many of my big blue-chip stocks.

Buy MBLY Stock to Play the Connected Car Market

By Richard Saintvilus, InvestorPlace Contributor May 12, 2015

With more automakers partnering with Mobileye, MBLY stock is poised to drive to $60 to $65 in the next 12 to 18 months, delivering gains of 20% to 30%.